Get started
Author

Andrew Lam

Observed name: Andrew Kwok Ping Lam
ORCID: 0000-0003-0036-7104
Observed ORCID: 0000-0003-0036-7104
OpenAlex ID: A5000763849
AI is a viable alternative to high throughput screening: a 318-target study
2024 · The Atomwise AIMS Program, Izhar Wallach, et al. · Scientific Reports · 133
DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer
2021 · Ning Shen, Sovannarith Korm, et al. · Communications Biology · 70
PDF
Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2021 · Nicole M. Anderson, Xiaodan Qin, et al. · Cancer Research · 69
PDF
CKLF instigates a “cold” microenvironment to promote MYCN-mediated tumor aggressiveness
2024 · Xiaodan Qin, Andrew Lam, et al. · Science Advances · 12
In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish
2020 · Xiaodan Qin, Fabrice F. J. Laroche, et al. · Journal of Visualized Experiments · 5
The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia
2020 · Yun Zhou, Haiwei Lian, et al. · Haematologica · 4
PDF
Author Correction: AI is a viable alternative to high throughput screening: a 318-target study
2024 · The Atomwise AIMS Program, Izhar Wallach, et al. · Scientific Reports · 3
PDF
In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish
2020 · Xiaodan Qin, Fabrice F. J. Laroche, et al. · Journal of Visualized Experiments · 3
T reg cells drive MYCN-mediated immunosuppression and tumor aggressiveness in high-risk neuroblastoma
2022 · Xiaodan Qin, Andrew Lam, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Abstract C002: CKLF attracts CCR4-expressing CD4+ cells to foster immune repression and tumor aggressiveness in MYCN-driven neuroblastoma
2024 · Xiaodan Qin, Hui Feng, et al. · Cancer Research
Abstract LB_C20: A tumor-associated chemokine attracts CCR4-expressing CD4+ cells to foster immune repression and tumor aggressiveness in MYCN-driven neuroblastoma
2023 · Xiaodan Qin, Andrew Lam, et al. · Molecular Cancer Therapeutics
Data from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
Figure S2 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
Figure S1 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
PDF
Figure S3 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
PDF
Supplementary Data_v1 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
Figure S5 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
PDF
Figure S6 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
PDF
Figure S7 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
Figure S4 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
Figure S6 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
Figure S5 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
Figure S2 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
PDF
Figure S1 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
Figure S3 from Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
2023 · Nicole M. Anderson, Xiaodan Qin, et al.
Works count: 31
Citation count: 300
H-index: 5
I10-index: 4
Year
Topic
Type